Abstract
The ongoing COVID-19 pandemic has demonstrated the shortcoming of epidemiological modelling for guiding policy decisions. Due to the lack of public data on infection spread in contact networks and individual courses of disease, current forecasting models rely heavily on unreliable population statistics and ad hoc parameters, resulting in forecasts with high uncertainty. To tackle the problem of insufficient public individual data, we develop an agent-based model to generate a synthetic Taiwanese COVID-19 dataset. We collected COVID-19 data from Taiwanese public databases for the period when the original SARS-CoV-2 virus was most prevalent (Jan.-Oct., 2020) and fit our model to it. We used the Firefly algorithm to optimize the 194 epidemiological parameters and validated the synthetic dataset by comparing it to Taiwanese public data. Here we study the difference between population statistics and individual course of disease data, and computational optimization of our code to reduce run time. The discrepancy between serum prevalence and reported cases, as well as excess deaths and reported deaths, show that population statistics are unreliable. Monte Carlo simulations further exemplify the discrepancy between actual and reported infections. By using Python CProfiler and Snakeviz packages, we iteratively optimize our algorithm and has so far decreased the computation time of the core code from 0.11s to 0.07s. The large computation time implies that we need to further optimize the algorithm.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding MOST 108-2811-E-006-046, 109-2224-F-006-003,110-2222-E-006-010, 111-2221-E-006-186 &110-2326-B-006-001-MY3
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
rain.wu{at}nordlinglab.org
torbjorn.nordling{at}nordlinglab.org
Funding MOST 108-2811-E-006-046, 109-2224-F-006-003, 110-2222-E-006-010, 111-2221-E-006-186 & 110-2326-B-006-001-MY3
Data Availability
All data produced in the present study are available upon reasonable request to the authors
